- International Agency for Research on Cancer. World Health Organization. Schistosomes, liver flukes and Helicobacter pylori. IARC Monographs. Evaluation of carcinogenic risks in humans 1994;61:177-240.
- Varis K, Ihamäki T, Härkönen M, Samloff IM, Siurala M. Gastric morphology, function, and immunology in first-degree relatives of proband s with pernicious anemia and controls. Scand J Gastroenterol 1979;14:129-39.
- Shevell MI, Rosenblatt DS. The neurology of cobolamin. Can J Neurol Sci 1992;19:472-86.
- Clarke I, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998;55:1149-55.
- Regland B, Gottfries CG, Lindstedt G. Dementia patients with low serum cobolamnin concentration. Relationship to atrophic gastritis. Aging (Milano) 1992;4:35-41.
- Yao Y, Yao SL, Yao SS, Yao G, Lou W. Prevalence of vitamin B12 deficiency among geriatric outpatients. J Fam Pract 1992; 35:524-8.
- Sipponen P, Kekki M. Haapakoski J, Ihamäki I, Siurala M. Gastric cancer risk in chronic atrophie gastritis:statistica 1 calculations of cross-sectional data. Int J Cancer 1985;35:173-7.
- Correa P. Human gastric carcinogenesis: multistep and multi-factorial process. Cancer Res 1992;52:6735-42.
- Valle J, Kekki M, Sipponen P, Ihamäki T, Siurala M. Long-term course and consequences of Helicobacte r pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol 1996;31:546-50.
- Varis K, Samloff IM, Ihamäki T, Siurala M. An appraisal of tests for severe atrophie gastritis in relatives of pernicious anemia. Dig Dis Sei 1979;24:187-91.
- Miki K, Ichinose M, Yahagi N, Suzuki T, Oka M, Shimizu Y, et al. Efficiency of gastric screening system using serum pepsinogen test. 2nd International Gastric Cancer Congress. Munich, Germany, 27-30 April 1997.
- Westerveld BD, Pals G, Lamers CB, Defize J, Pronk JC, Frants RR, et al. Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels. Cancer 1987;59:952-8.
- Yoshihara M, Sumii K, Haruma K, Kiyohira K, Hattori N, Kitadai Y, et al. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol 1998;93:1090-6.
- Borch K, Axelsson CK, Halgreen H, Damkjaer Nielsen MD, Ledin T, Szesci PB. The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophie gastritis. Scand J Gastroenterol 1989; 24:870-6.
- Kekki M, Samloff IM, Varis K, Ihamäki T. Serum pepsinogen serum and I gastrin in screening of severe atrophie corpus gastritis. Scand J Gastroenterol 1991;186:109-16.
- Sipponen P, Valle J, Varis K, Kekki M, Ihamäki T, Siurala M. Fasting levels of serum gastrin in different functional and morphological states of the antro-fundal mucosa. An analysis of 860 subjects. Scand J Gastroenterol 1990;25:513-9.
- Den Hartog G, Jansen JB, Schaardenburg DJ, Lamberts EJ, van de Boomgaard RM, Kreuning J, et al. Plasma gastrin responses to bombesin and antrat gastrin concentrations in patients with the intestinal type gastric cancer. Cancer Res 1988;48:2296-8.
- Sipponen P, Seppälä K, Äärynen M, Helske T, Kettunen P. Chronic gastritis and gastroduodenal ulcer: a case control study of coexisting duodenal or gastric ulcer in patients with chronic gastritis. Gut 1989;30:922-9.
- Sipponen P, Varis K, Fräki O, Korri UM, Seppälä K, Siurala M. Cumulative 10-year risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis. A clinical follow-up study of 454 outpatients. Scand J Gastroenterol 1990; 25:966-73.
- Varis K, Sipponen P, Laxén F, Samloff IM, Huttunen J, Taylor PR, et al. Implication s of serum pepsinoge n I in early endoscopic diagnosis of gastric cancer and dysplasia. Scand J Gastroenterol 2000;35:950-6.
- Varis K, Taylor PR, Sipponen P, Samloff IM, Heinonen OP, Albanes D, et al. Gastric cancer and premalignant lesions in atrophie gastritis: a controlled trial on the effect of supplementation with alpha-tocopherol and beta-carotene. Scand J Gastroenterol 1998;33:294-300.
- Varis K, Kekki M, Härkönen M, Sipponen P, Samloff IM. Serum pepsinogen I and serum gastrin in the screening of atrophie pangastritis with high risk of gastric cancer. Scand J Gastroenterol 1991;186:117-23.
- Miki K, Ichinose M, Ishikawa KB, Yahagi N, Matsushima M, Kakei N, et al. Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer. Jpn J Cancer Res 1993;84:1086-90.
- Miki K, Ichinose M, Shimizu A, Huang SC, Oka H, Furihata C, et al. Serum pepsinogen s as a screening test of extensive chronic gastritis. Gastroenterol Jpn 198722;133-41.
- Hattori Y, Tashiro H, Kawamoto T, Kodama Y. Sensitivity and specificity of mass screening for gastric cancer using the measurement of serum pepsinogens. Jpn J Cancer Res 1995;86:1210-5.
- Kodoi A, Yoshihara M, Sumii K, Manama K, Kajiyama G. Serum pepsinogen in screening for gastric cancer. J Gastroenterol 1995; 30:452-60.
- Aoki K, Misumi J, Kimura T, Zhao W, Xie T. Evaluation of cut-off levels for screening of gastric cancer using serum pepsinogens and distribution of levels of serum pepsinogen I, II and of PG1/PGII ratios in a gastric cancer case-control study. J Epidemiol 1997;7:143-51.
- Kikuchi S, Wada O, Miki K, Nakajima T, Nishi T, Kobayashi O, et al. Serum pepsinogen as a new marker for gastric carcinoma among young adults. Research group on prevention of gastric carcinoma among young adults. Cancer 1994;73:2695-702.
- Nomura AM, Stemmermann GN, Samloff IM. Serum pepsinogen I as a predictor of stomach cancer. Ann Intern Med 1980;93:537-40.
- Hallissey MT, Dunn JA, Fielding JW. Evaluation of pepsinogen A and gastrin-17 as markers of gastric cancer and high-risk pathologic conditions. Scand J Gastroenterol 1994;29:1129-34.
Scandinavian Journal of Gastroenterology
Volume 37, 2002 - Issue 7